532-nm Subthreshold Micropulse Laser for the Treatment of Chronic Central Serous Retinopathy.

Keissy SousaGil Calvão-SantosMarina JoãoNuno GomesManuel S Falcão

Published in: Clinical ophthalmology (Auckland, N.Z.) (2020)

In this study, 532-SML was overall ineffective on cCSR as it did not lead to significant changes in the overall median visual acuity and SD-OCT parameters. However, some patients may have benefited functionally and anatomically from the treatment; further investigation is necessary to understand the potential of 532-SML.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
high grade
photodynamic therapy
risk assessment
peritoneal dialysis
patient reported outcomes
diabetic retinopathy
mass spectrometry
human health